Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Low-Grade Glioma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00138216
What this trial is testing

Temozolomide, Vincristine, and Irinotecan in Treating Young Patients With Refractory Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsUnspecified Childhood Solid Tumor, Protocol Specific
Children's Oncology Group 42
Early research (Phase 1)Study completedNCT00901849
What this trial is testing

Tarceva/Rapamycin for Children With Low-grade Gliomas With or Without Neurofibromatosis Type 1 (NF1)

Who this might be right for
Low-grade Gliomas
Roger Packer 21
Testing effectiveness (Phase 2)Study completedNCT00826241
What this trial is testing

Dose-Dense Temozolomide + Lapatinib for Recurrent Ependymoma

Who this might be right for
Brain TumorsSpinal Cord Tumors
National Institutes of Health Clinical Center (CC) 58
Not applicableStudy completedNCT00002485
What this trial is testing

Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+8 more
Children's Oncology Group 359
Testing effectiveness (Phase 2)WithdrawnNCT05222165
What this trial is testing

Study With Infigratinib in Subjects With Advanced Solid and CNS Tumors or Recurrent or Progressive Low-Grade Glioma With Selected FGFR1-3 Alterations

Who this might be right for
Advanced Solid TumorCNS TumorRecurrent WHO Grade II Glioma
Helsinn Healthcare SA
Testing effectiveness (Phase 2)Study completedNCT01734512
What this trial is testing

PNOC 001: Phase II Study of Everolimus for Recurrent or Progressive Low-grade Gliomas in Children

Who this might be right for
Pediatric Recurrent Progressive Low-grade GliomasPediatric Progressive Low-grade Gliomas
University of California, San Francisco 65
Testing effectiveness (Phase 2)Looking for participantsNCT02358187
What this trial is testing

A Vaccine Trial for Low Grade Gliomas

Who this might be right for
Low Grade Glioma
James Felker 25
Testing effectiveness (Phase 2)Ended earlyNCT01887522
What this trial is testing

Study of Vinblastine in Combination With Nilotinib in Children, Adolescents, and Young Adults

Who this might be right for
Refractory Low-grade GliomasRecurrent Low-grade Gliomas
Gustave Roussy, Cancer Campus, Grand Paris 144
Testing effectiveness (Phase 2)Study completedNCT01081223
What this trial is testing

Phase I/II Study To Test The Safety and Efficacy of TVI-Brain-1 As A Treatment For Recurrent Grade IV Glioma

Who this might be right for
GliomaHigh Grade AstrocytomaGlioblastoma Multiforme
TVAX Biomedical 12
Not applicableUnknownNCT02416999
What this trial is testing

Ultra-low Dose Bevacizumab Plus Temozolomide for Recurrent High-grade Gliomas

Who this might be right for
Recurrent High-grade Glioma
Hebei Yanda Hospital 30
Testing effectiveness (Phase 2)Study completedNCT03213665
What this trial is testing

Tazemetostat in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With EZH2, SMARCB1, or SMARCA4 Gene Mutations (A Pediatric MATCH Treatment Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmAnn Arbor Stage III Hodgkin LymphomaAnn Arbor Stage III Non-Hodgkin Lymphoma+38 more
National Cancer Institute (NCI) 20
Testing effectiveness (Phase 2)Study completedNCT00003467
What this trial is testing

Carmustine in Treating Adults With Recurrent Supratentorial Low-Grade Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Duke University 68
Testing effectiveness (Phase 2)Study completedNCT00381797
What this trial is testing

Bevacizumab and Irinotecan in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma, Medulloblastoma, Ependymoma, or Low Grade Glioma

Who this might be right for
Childhood Cerebral Anaplastic AstrocytomaChildhood OligodendrogliomaChildhood Spinal Cord Neoplasm+3 more
National Cancer Institute (NCI) 97
Early research (Phase 1)Study completedNCT00272350
What this trial is testing

ZD6474 to Treat Advanced Brain Cancer in Patients

Who this might be right for
Recurrent High-Grade GliomasProgressive Low-Grade GliomasMalignant Gliomas
National Cancer Institute (NCI) 83
Testing effectiveness (Phase 2)Looking for participantsNCT04923126
What this trial is testing

SJ901: Evaluation of Mirdametinib in Children, Adolescents, and Young Adults With Low-Grade Glioma

Who this might be right for
Low-Grade GliomaRecurrent Low-Grade GliomaProgressive Low-Grade Glioma
St. Jude Children's Research Hospital 132
Early research (Phase 1)Study completedNCT01884922
What this trial is testing

Study Of Vinblastine in Combination With Nilotinib in Children, Adolescents and Young Adults

Who this might be right for
Refractory Low-grade GliomasRecurrent Low-grade Gliomas
Gustave Roussy, Cancer Campus, Grand Paris 35
Early research (Phase 1)Study completedNCT00946335
What this trial is testing

ABT-888 and Temozolomide in Treating Young Patients With Recurrent or Refractory CNS Tumors

Who this might be right for
Childhood Atypical Teratoid/Rhabdoid TumorChildhood Central Nervous System Germ Cell TumorChildhood Choroid Plexus Tumor+25 more
National Cancer Institute (NCI) 31
Large-scale testing (Phase 3)Active Not RecruitingNCT00978458
What this trial is testing

Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma

Who this might be right for
Brain and Central Nervous System TumorsNeurotoxicity
Eastern Cooperative Oncology Group 540
Testing effectiveness (Phase 2)UnknownNCT00005084
What this trial is testing

Magnetic Resonance Imaging in Treating Children With Progressive Low-Grade Astrocytoma

Who this might be right for
Brain and Central Nervous System Tumors
Jonsson Comprehensive Cancer Center 24
Testing effectiveness (Phase 2)Study completedNCT00238264
What this trial is testing

Radiation Therapy in Treating Young Patients With Gliomas

Who this might be right for
Brain TumorCentral Nervous System Tumor
Children's Oncology Group 92
Next Page